Marten Snel

Dr, PhD

  • 843 Citations
  • 12 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Public Profile

Marten completed his PhD in the MS analysis of synthetic polymers at Edinburgh University in 1999.   On completion of his studies he worked for Waters Corporation for nine years in both commercial and scientific roles, including spearheading the development of MALDI imaging combined with ion mobility separation.

He and his family moved to Adelaide in 2009 where he took up a role with the Lysosomal Diseases Research Unit at the Women’s and Children’s Hospital and later SAHMRI.  Here he and his team used mass spectrometry to study lipids, glycosaminoglycans, neurotransmitters and proteins in mucopolysaccharidoses and Gaucher disease. 

In 2019, Marten became the Head of SAHMRI’s Proteomics, Metabolomics and MS-Imaging Core Facility.  His research interests include comprehensive high throughput characterisation of patient derived samples using lipidomics and proteomics, and the in-situ analysis of lipids and other small molecules in tissues using laser-based mass spectrometry. 

Education/Academic qualification

PhD, University of Edinburgh

Bachelor of Science (Honours), University of Edinburgh

External positions

Affiliate Senior Lecturer, University of Adelaide

1 Dec 2009 → …


  • Mass Spectrometry
  • Proteomics
  • MS-imaging
  • Lipidomics
  • Metabolomics
  • Bioanalysis

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 843 Citations
  • 12 h-Index
  • 32 Article
  • 1 Chapter
  • 1 Review article

Developing a multivariable prediction model for functional outcome after reperfusion therapy for acute ischaemic stroke: study protocol for the Targeting Optimal Thrombolysis Outcomes (TOTO) multicentre cohort study

Holliday, E., Lillicrap, T., Kleinig, T., Choi, P. M. C., Maguire, J., Bivard, A., Lincz, L. F., Hamilton-Bruce, M. A., Rao, S. R., Snel, M. F., Trim, P. J., Lin, L., Parsons, M. W., Worrall, B. B., Koblar, S., Attia, J. & Levi, C., 6 Apr 2020, In : BMJ Open. 10, 4, p. e038180 038180.

Research output: Contribution to journalArticle

Reciprocal signaling between mTORC1 and MNK2 controls cell growth and oncogenesis

Xie, J., Shen, K., Jones, A. T., Yang, J., Tee, A. R., Shen, M. H., Yu, M., Irani, S., Wong, D., Merrett, J. E., Lenchine, R. V., De Poi, S., Jensen, K., Trim, P., Snel, M., Kamei, M., Martin, S., Fitter, S., Tian, S., Wang, X. & 3 others, Butler, L., Zannettino, A. & Proud, C., 1 Jan 2020, In : Cellular and Molecular Life Sciences.

Research output: Contribution to journalArticle

1 Citation (Scopus)

AAVrh10 vector corrects disease pathology in MPS IIIA mice and achieves widespread distribution of SGSH in large animal brains

Hocquemiller, M., Hemsley, K. M., Douglass, M. L., Tamang, S., Neumann, D., King, B., Beard, H., Trim, P., Winner, L., Bowen, A., Snel, M., Gomila, C., Ausseil, J., Mei, X., Giersch, L., Plavsic, M. & Laufer, R., 9 Dec 2019, In : Molecular Therapy - Methods and Clinical Development. 17, p. 174-187 14 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Early disease course is unaltered in mucopolysaccharidosis type IIIA (MPS IIIA) mice lacking α-synuclein

Soe, K., Beard, H., Neumann, D., Trim, P., Duplock, S., Snel, M., Hopwood, J. & Hemsley, K., 1 Dec 2019, In : Neuropathology and Applied Neurobiology. 45, 7, p. 715-731 17 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Evaluation of Small Molecule Drug Uptake in Patient-Derived Prostate Cancer Explants by Mass Spectrometry

Mutuku, S. M., Trim, P. J., Prabhala, B. K., Irani, S., Bremert, K. L., Logan, J. M., Brooks, D. A., Stahl, J., Centenera, M. M., Snel, M. F. & Butler, L. M., 1 Dec 2019, In : Scientific reports. 9, 1, 15008.

Research output: Contribution to journalArticle

2 Citations (Scopus)